Cost-Effectiveness of Extended-Release Methylphenidate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder Sub-Optimally Treated with Immediate Release Methylphenidate

• Jurjen van der Schans ,

  * E-mail: j.van.der.schans@rug.nl (JvdS); m.j.postma@rug.nl (MJP)

  Affiliation Unit of PharmacoEpidemiology & PharmacoEconomics (PE2), Department of Pharmacy, University of Groningen (RUG), Groningen, the Netherlands

  ⨯
• Nikos Kotsopoulos,

  Affiliation Unit of PharmacoEpidemiology & PharmacoEconomics (PE2), Department of Pharmacy, University of Groningen (RUG), Groningen, the Netherlands

  ⨯
• Pieter J. Hoekstra,

  Affiliation University of Groningen, University Medical Center Groningen, Department of Psychiatry, Groningen, the Netherlands

  ⨯
• Eelko Hak,

  Affiliation Unit of PharmacoEpidemiology & PharmacoEconomics (PE2), Department of Pharmacy, University of Groningen (RUG), Groningen, the Netherlands

  ⨯
• Maarten J. Postma

  * E-mail: j.van.der.schans@rug.nl (JvdS); m.j.postma@rug.nl (MJP)

  Affiliations Unit of PharmacoEpidemiology & PharmacoEconomics (PE2), Department of Pharmacy, University of Groningen (RUG), Groningen, the Netherlands, University of Groningen, University Medical Center Groningen, Institute of Science in Healthy Aging & healthcaRE, Groningen, the Netherlands

  ⨯